Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 15 results:
Author Title Type [ Year(Asc)]
Filters: Author is Rietbrock, S.  [Clear All Filters]
2020
C. Martinez, Wallenhorst, C., Rietbrock, S., and Freedman, B., “Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study”, J Am Heart Assoc, vol. 9, p. e014376, 2020.
2019
V. Cairns, Wallenhorst, C., Rietbrock, S., and Martinez, C., “Incidence of Lyme disease in the UK: a population-based cohort study”, BMJ Open, vol. 9, p. e025916, 2019.
2018
C. Martinez, Katholing, A., Folkerts, K., and Rietbrock, S., “Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study”, Curr Med Res Opin, vol. 34, pp. 1985-1990, 2018.
2017
A. T. Cohen, Katholing, A., Rietbrock, S., Bamber, L., and Martinez, C., “Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study”, Thromb Haemost, vol. 117, pp. 57-65, 2017.
2016
B. Freedman, Martinez, C., Katholing, A., and Rietbrock, S., “Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation”, JAMA Cardiol, vol. 1, pp. 366-8, 2016.
C. Martinez, Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., and Handelsman, D. J., “Testosterone treatment and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 355, p. i5968, 2016.
2014
C. Martinez, Cohen, A. T., Bamber, L., and Rietbrock, S., “Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer”, Thromb Haemost, vol. 112, pp. 255-63, 2014.
2013
C. Martinez, Jones, R. W., and Rietbrock, S., “Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study”, BMJ Open, vol. 3, 2013.
2009
S. Rietbrock, Plumb, J. M., Gallagher, A. M., and van Staa, T. P., “How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database”, Thromb Haemost, vol. 101, pp. 527-34, 2009.
S. Rietbrock, Olson, M., and van Staa, T. P., “The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates”, Qjm, vol. 102, pp. 35-42, 2009.
2008
S. Rietbrock, Heeley, E., Plumb, J., and Van Staa, T., “Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme”, Am Heart J, vol. 156, pp. 57-64, 2008.
T. P. van Staa, Rietbrock, S., Setakis, E., and Leufkens, H. G., “Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?”, J Intern Med, vol. 264, pp. 481-92, 2008.
A. M. Gallagher, Rietbrock, S., Olson, M., and van Staa, T. P., “Fracture outcomes related to persistence and compliance with oral bisphosphonates”, J Bone Miner Res, vol. 23, pp. 1569-75, 2008.
A. M. Gallagher, Rietbrock, S., Plumb, J., and van Staa, T. P., “Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?”, J Thromb Haemost, vol. 6, pp. 1500-6, 2008.
2005
C. Martinez, Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., and Gunnell, D., “Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study”, Bmj, vol. 330, p. 389, 2005.
[Page last reviewed 6 April 2021]